GLOBAL DOUBLE STANDARDS
 |
James Joyner | Wednesday, July 30, 2003 |
Robert Kuttner thinks we’re being inconsistent by, on the one hand, exporting low skill jobs to India to take advantage of their lower labor costs but, on the other hand, refusing to import drugs from India produced in violation if US patent and drug approval laws. Well…..no.
It may well be worth reconsidering our drug approval process and the length of patent and copyright protections. But these are separate arguments. A US company can’t reverse engineer a patented product and sell it here, either. Nor can a US company sell drugs that aren’t FDA approved.
About the Author: James Joyner is the publisher of Outside the Beltway and the managing editor of the Atlantic Council. He's a former Army officer, Desert Storm vet, and college professor with a PhD in political science from The University of Alabama. He lives just outside the Beltway in Alexandria, Virginia with his wife and infant daughter.
Follow James on FriendFeed | Twitter | Digg
Related Stories:
- None Found
Recent Stories:
- Caption Contest Winners
- OTB Latenight – Styx
- Berlin Wall Fall: 20 Years Later
- Oklahoma High Schoolers Are Very Familiar With George Washington, Thanks
- Was Fort Hood Massacre ‘Terrorism’?
- Making Jobs More Expensive
- House Trades Freedom for Health Coverage, Senate’s Move
- Hasan a Muslim First, American Second?
- OTB Caption JamTM
- Taking “No” As Iran’s Answer
Comments
Comments are Closed
